Chronic cough: An update

Mayo Clinic Proceedings

Volumn 88, Issue 10, 2013, Pages 1115-1126

  Iyer, Vivek N ^a   Lim, Kaiser G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; AZELASTINE; CORTICOSTEROID; DECONGESTIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUNISOLIDE; GABAPENTIN; IPRATROPIUM BROMIDE; LIDOCAINE; METHACHOLINE; PROTON PUMP INHIBITOR;

ALGORITHM; ANXIETY; ASTHMA; BRONCHITIS; CHRONIC BRONCHITIS; CHRONIC COUGH; DISEASE DURATION; DRUG USE; GASTROESOPHAGEAL REFLUX; HUMAN; OUTPATIENT DEPARTMENT; QUALITY OF LIFE; REVIEW; SMOKING; SOCIAL ISOLATION;

EID: 84888618986     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.08.007     Document Type: Review

References (149)

1. Kuzniar TJ, Morgenthaler TI, Afessa B, Lim KG. Chronic cough from the patient's perspective. Mayo Clin Proc. 2007;82(1):56-60.
2. French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Intern Med. 1998;158(15): 1657-1661.
3. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MDL, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339-343.
4. Brooks SM. Perspective on the human cough reflex. Cough. 2011;7:10.
5. Kelsall A, Houghton LA, Jones H, Decalmer S, McGuinness K, Smith JA. A novel approach to studying the relationship between subjective and objective measures of cough. Chest. 2011;139(3):569-575.
6. Sasaki C. Anatomy and development and physiology of the larynx. In: Goyal R, Shaker R, eds. Shaker and Goyal GI Motility Online-Part 1 Oral Cavity, Pharynx and Esophagus. London, England: Nature Publishing Group; 2008. http://www.nature.com/gimo/contents/pt1/full/gimo7.html. Accessed September 3, 2013.
7. Kwon S-B, Park J, Jang J, et al. Study on the initial velocity distribution of exhaled air from coughing and speaking. Chemosphere. 2012;87(11):1260-1264.
8. Lavorini F, Fontana GA, Chellini E, Magni C, Duranti R, Widdicombe J. Desensitization of the cough reflex by exercise and voluntary isocapnic hyperpnea. J Appl Physiol. 2010; 108(5):1061-1068.
9. Bolser DC. A streetcar named urge-to-cough. J Appl Physiol. 2010;108(5):1030-1031.
10. Mazzone S, McGovern A, Yang S-K, et al. Sensorimotor circuitry involved in the higher brain control of coughing. Cough. 2013;9(1):7.
11. Vertigan A, Gibson P. The role of speech pathology in the management of patients with chronic refractory cough. Lung. 2012;190(1):35-40.
12. Fass R. Effect of gastroesophageal reflux disease on sleep. J Gastroenterol Hepatol. 2010;25(suppl 1):S41-S44.
13. Mazzone SB, Cole LJ, Ando A, Egan GF, Farrell MJ. Investigation of the neural control of cough and cough suppression in humans using functional brain imaging. J Neurosci. 2011;31(8): 2948-2958.
14. Davenport P, Vovka A, Dukea R, Bolsera D, Robertson E. The urge-to-cough and cough motor response modulation by the central effects of nicotine. Pulm Pharmacol Ther. 2009;22(2): 82-89.
15. Yoshida Y, Tanaka Y, Hirano M, Nakashima T. Sensory innervation of the pharynx and larynx. Am J Med. 2000;108(suppl 4a):51S-61S.
16. Canning B. Encoding of the cough reflex. Pulm Pharmacol Ther. 2007;20(4):396-401.
17. Kollarik M, Ru F, Brozmanova M. Vagal afferent nerves with the properties of nociceptors. Auton Neurosci. 2010; 153(1-2):12-20.
18. Mazzone S, McLennan L, McGovern A, Eagan G, Farrell M. Representation of capsaicin-evoked urge to cough in the human brain using functional magnetic resonance imaging. Am J Respir Crit Care Med. 2007;176(4):327-332.
19. Davenport PW, Bolser DC, Vickroy T, et al. The effect of codeine on the Urge-to-Cough response to inhaled capsaicin. Pulm Pharmacol Ther. 2007;20(4):338-346.
20. Morice AH, Menon MS, Mulrennan SA, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med. 2007;175(4): 312-315.
21. Lee B, Woo P. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol. 2005;114(4):253-257.
22. Murry T, Branski RC, Yu K, Cukier-Blaj S, Duflo S, Aviv JE. Laryngeal sensory deficits in patients with chronic cough and paradoxical vocal fold movement disorder. Laryngoscope. 2010;120(8):1576-1581.
23. Davenport PW, Vovk A, Duke RK, Bolser DC, Robertson E. The urge-to-cough and cough motor response modulation by the central effects of nicotine. Pulm Pharmacol Ther. 2009;22(2):82-89.
24. Groneberg D, Quarcoo D, Frossard N, Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy. 2004; 59(11):1139-1152.
25. Leech J, Mazzone SB, Farrell MJ. The effect of placebo conditioning on capsaicin-evoked urge to cough. Chest J. 2012; 142(4):951-957.
26. Ryan N, Vertigan A, Gibson P. Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement. Cough. 2009;5:4.
27. McGarvey L, McKeagney P, Polley L, MacMahon J, Costello RW. Are there clinical features of a sensitized cough reflex? Pulm Pharmacol Ther. 2009;22(2):59-64.
28. Ford AC, Forman D, Moayyedi P, Morice AH. Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax. 2006;61(11):975-979.
29. Smith JA, Decalmer S, Kelsall A, et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology. 2010;139(3):754-762.
30. Janson C, Chinn S, Jarvis D, Burney P. Determinants of cough in young adults participating in the European Community Respiratory Health Survey. Eur Respir J. 2001;18(4):647-654.
31. Kelsall A, Decalmer S, McGuinness K, Woodcock A, Smith JA. Sex differences and predictors of objective cough frequency in chronic cough. Thorax. 2009;64(5):393-398.
32. Fujimura M, Kasahara K, Kamio Y, Naruse M, Hashimoto T, Matsuda T. Female gender as a determinant of cough threshold to inhaled capsaicin. Eur Respir J. 1996;9(8):1624-1626.
33. Kastelik JA, Thompson RH, Aziz I, Ojoo JC, Redington AE, Morice AH. Sex-related differences in cough reflex sensitivity in patients with chronic cough. Am J Respir Crit Care Med. 2002;166(7):961-964.
34. Boulet LP, Milot J, Boutet M, St Georges F, Laviolette M. Airway inflammation in nonasthmatic subjects with chronic cough. Am J Respir Crit Care Med. 1994;149(2):482-489.
35. Dicpinigaitis PV. Angiotensin-converting enzyme inhibitorinduced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1, suppl):169S-173S.
36. French CT, Fletcher KE, Irwin RS. Gender differences in health-related quality of life in patients complaining of chronic cough. Chest. 2004;125(2):482-488.
37. Brignall K, Jayaraman B, Birring S. Quality of life and psychosocial aspects of cough. Lung. 2008;186(suppl 1):S55-S58.
38. French CT, Irwin RS, Fletcher KE, Adams TM. EValuation of a cough-specific quality-of-life questionnaire. Chest. 2002; 121(4):1123-1131.
39. Kelchner LN, Horne J, Lee L, et al. Reliability of speechlanguage pathologist and otolaryngologist ratings of laryngeal signs of reflux in an asymptomatic population using the reflux finding score. J Voice. 2007;21(1):92-100.
40. Krahnke J, Gentile D, Angelini D, Danzig M, Skoner D. Comparison of objective and subjective measurements of cough frequency in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;93(3):259-264.
41. Decalmer S, Woodcock A, Greaves M, Howe M, Smith J. Airway abnormalities at flexible bronchoscopy in patients with chronic cough. Eur Respir J. 2007;30(6):1138-1142.
42. Marsden PA, Smith JA, Kelsall AA, et al. A comparison of objective and subjective measures of cough in asthma. J Allergy Clin Immunol. 2008;122(5):903-907.
43. Decalmer SC, Webster D, Kelsall AA, McGuinness K, Woodcock AA, Smith JA. Chronic cough: how do cough reflex sensitivity and subjective assessments correlate with objective cough counts during ambulatory monitoring? Thorax. 2007;62(4):329-334.
44. Kavitt RT, Higginbotham T, Slaughter JC, et al. Symptom reports are not reliable during ambulatory reflux monitoring. Am J Gastroenterol. 2012;107(12):1826-1832.
45. Khuri SF, Daley J, Henderson WG. The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs. Arch Surg. 2002;137(1): 20-27.
46. Irwin RS, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1, suppl):1S-23S.
47. Chang AB, Lasserson TJ, Gaffney J, Connor Frances L, Garske LA. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev. 2011;(1):CD004823.
48. Wei CC, Adappa ND, Cohen NA. Use of topical nasal therapies in the management of chronic rhinosinusitis [published online April 1, 2013]. Laryngoscope. doi: 10. 1002/lary.24066.
49. Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet. 2008;371(9621):1364-1374.
50. Mello CJ, Irwin RS, Curley FJ. Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch Intern Med. 1996;156(9):997-1003.
51. Smyrnios NA, Irwin RS, Curley FJ. Chronic cough with a history of excessive sputum production: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest. 1995; 108(4):991-997.
52. Irwin RS. Introduction to the diagnosis and management of cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1, suppl):25S-27S.
53. Irwin RS. Unexplained cough in the adult. Otolaryngol Clin North Am. 2010;43(1):167-180, xi-xii.
54. Dicpinigaitis PV. Angiotensin-converting enzyme inhibitorinduced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1, suppl):169S-173S.
55. Bloustine S, Langston L, Miller T. Ear-cough (Arnold's) reflex. Ann Otol Rhinol Laryngol. 1976;85(3):406-407.
56. Hahn PY, Morgenthaler TY, Lim KG. Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough. Mayo Clin Proc. 2007;82(11):1350-1355.
57. Lin L, Poh K, Lim T. Empirical treatment of chronic cough: a cost-effectiveness analysis. Proc AMIA Symp. 2001;2001: 383-387.
58. Shaheen NJ, Crockett SD, Bright SD, et al. Randomised clinical trial: high-dose acid suppression for chronic cough: a doubleblind, placebo-controlled study. Aliment Pharmacol Ther. 2011; 33(2):225-234.
59. Faruqi S, Molyneux ID, Fathi H, Wright C, Thompson R, Morice AH. Chronic cough and esomeprazole: a doubleblind placebo-controlled parallel study. Respirology. 2011; 16(7):1150-1156.
60. Reichel O, Dressel H, Wiederänders K, Issing WJ. Doubleblind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. Otolaryngol Head Neck Surg. 2008;139(3):414-420.
61. Lee W, Yeh Y, Lacy B, et al. Timely confirmation of gastroesophageal reflux disease via pH monitoring: estimating budget impact on managed care organizations. Curr Med Res Opin. 2008;24(5):1317-1327.
62. Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(suppl 1):i1-i24.
63. Tatar M, Plevkova J, Brozmanova M, Pecova R, Kollarik M. Mechanisms of the cough associated with rhinosinusitis. Pulm Pharmacol Ther. 2009;22(2):121-126.
64. Palombini BC, Villanova CA, Araujo E, et al. A pathogenic triad in chronic cough: asthma, postnasal drip syndrome, and gastroesophageal reflux disease. Chest. 1999;116(2):279-284.
65. Irwin RS, Boulet LP, Cloutier MM, et al. Managing cough as a defense mechanism and as a symptom: a consensus panel report of the American College of Chest Physicians. Chest. 1998;114(2, suppl managing):133S-181S.
66. Morice AH, Kastelik JA. Cough, 1: chronic cough in adults. Thorax. 2003;58(10):901-907.
67. Irwin RS, Madison JM. Anatomical diagnostic protocol in evaluating chronic cough with specific reference to gastroesophageal reflux disease. Am J Med. 2000;108(suppl 4a): 126S-130S.
68. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129(3, suppl): S1-S32.
69. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114(6, suppl):155-212.
70. Pearson JP, Parikh S, Orlando RC, et al. Review article: reflux and its consequences: the laryngeal, pulmonary and oesophageal manifestations: conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010. Aliment Pharmacol Ther. 2011;33(suppl 1):1-71.
71. Pratter MR. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1, suppl):63S-71S.
72. Morice AH, Fontana GA, Sovijarvi AR, et al. The diagnosis and management of chronic cough. Eur Respir J. 2004;24(3):481-492.
73. Lim KG, Rank MA, Kita H, Patel A, Moore E. Neuropeptide levels in nasal secretions from patients with and without chronic cough. Ann Allergy Asthma Immunol. 2011;107(4):360-363.
74. Pratter MR, Bartter T, Akers S, DuBois J. An algorithmic approach to chronic cough. Ann Intern Med. 1993;119(10): 977-983.
75. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol. 2003;111(6):1171-1183; quiz 1184.
76. Yousem DM. Imaging of sinonasal inflammatory disease. Radiology. 1993;188(2):303-314.
77. Vaezi MF, Hagaman DD, Slaughter JC, et al. Proton pump inhibitor therapy improves symptoms in postnasal drainage. Gastroenterology. 2010;139(6):1887- 1893.e1881; quiz e11.
78. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900-1920; quiz 1943.
79. Bhattacharyya N. Clinical and symptom criteria for the accurate diagnosis of chronic rhinosinusitis. Laryngoscope. 2006; 116(7, suppl 110):1-22.
80. Stewart MG, Sicard MW, Piccirillo JF, Diaz-Marchan PJ. Severity staging in chronic sinusitis: are CT scan findings related to patient symptoms? Am J Rhinol. 1999;13(3):161-167.
81. Stankiewicz JA, Chow JM. A diagnostic dilemma for chronic rhinosinusitis: definition accuracy and validity. Am J Rhinol. 2002;16(4):199-202.
82. Kastelik JA, Aziz I, Ojoo JC, Thompson RH, Redington AE, Morice AH. Investigation and management of chronic cough using a probability-based algorithm. Eur Respir J. 2005;25(2): 235-243.
83. Smyrnios NA, Irwin RS, Curley FJ, French CL. From a prospective study of chronic cough: diagnostic and therapeutic aspects in older adults. Arch Intern Med. 1998;158(11):1222-1228.
84. McGarvey LP, Heaney LG, Lawson JT, et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax. 1998;53(9): 738-743.
85. McKenzie S. Cough: but is it asthma? Arch Dis Child. 1994;70: 1-2.
86. Spanevello A, Confalonieri M, Sulotto F, et al. Induced sputum cellularity: reference values and distribution in normal volunteers. Am J Respir Crit Care Med. 2000;162(3):1172-1174.
87. Belda J, Leigh R, Parameswaran K, O'Byrne PM, Sears MR, Hargreave FE. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med. 2000;161(2):475-478.
88. Merchant R, Schwartz D, Helmers R, Dayton C, Hunninghake G. Bronchoalveolar lavage cellularity: the distribution in normal volunteers. Am Rev Respir Dis. 1992; 146(2):448-453.
89. Glauser F. Variant asthma. Ann Allergy. 1972;30(8):457-459.
90. Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med. 1979;300(12):633-637.
91. Johnson D, PO sborn L. Cough variant asthma: a review of the clinical literature. J Asthma. 1991;28(2):85-90.
92. Cockcroft DW. Direct challenge tests airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010;138(2, suppl):18S-24S.
93. Ponsioen BP, Hop WC, Vermue NA, Dekhuijzen PN, Bohnen AM. Efficacy of fluticasone on cough: a randomised controlled trial. Eur Respir J. 2005;25(1):147-152.
94. Ribeiro M, Pereira CA, Nery LE, Beppu OS, Silva CO. Highdose inhaled beclomethasone treatment in patients with chronic cough: a randomized placebo-controlled study. Ann Allergy Asthma Immunol. 2007;99(1):61-68.
95. Chaudhuri R, McMahon AD, Thomson LJ, et al. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. J Allergy Clin Immunol. 2004;113(6):1063-1070.
96. Davies MJ, Fuller P, Picciotto A, McKenzie SA. Persistent nocturnal cough: randomised controlled trial of high dose inhaled corticosteroid. Arch Dis Child. 1999;81(1):38-44.
97. Brightling CE. Cough due to asthma and nonasthmatic eosinophilic bronchitis. Lung. 2010;188(suppl 1):S13-S17.
98. Hancox RJ, Leigh R, Kelly MM, Hargreave FE. Eosinophilic bronchitis. Lancet. 2001;358(9287):1104.
99. Berry MA, Hargadon B, McKenna S, et al. Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy. 2005;35(5):598-601.
100. Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma. Eur Respir J. 1999; 14(5):1228-1230.
101. Lim KG. Nitric oxide measurement in chronic cough. Lung. 2010;188(suppl 1):S19-S22.
102. See KC, Christiani DC. Normal values and thresholds for the clinical interpretation of exhaled nitric oxide levels in the us general population: results from the National Health and Nutrition Examination survey 2007-2010. Chest. 2013; 143(1):107-116.
103. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602-615.
104. Stewart L, Katial RK. Exhaled nitric oxide. Immunol Allergy Clin North Am. 2012;32(3):347-362.
105. Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA. 2005;294(12):1534-1540.
106. Sun G, Muddana S, Slaughter JC, et al. A new pH catheter for laryngopharyngeal reflux: normal values. Laryngoscope. 2009; 119(8):1639-1643.
107. Maldonado A, Diederich L, Castell DO, Gideon RM, Katz PO. Laryngopharyngeal reflux identified using a new catheter design: defining normal values and excluding artifacts. Laryngoscope. 2003;113(2):349-355.
108. Vaezi MF, Hicks DM, Abelson TI, Richter JE. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1(5):333-344.
109. Irwin RS. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1, suppl):80S-94S.
110. Poe RH, Harder RV, Israel RH, Kallay MC. Chronic persistent cough: experience in diagnosis and outcome using an anatomic diagnostic protocol. Chest. 1989;95(4):723-728.
111. Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis. 1981;123(4):413-417.
112. Dent J, Vakil N, Jones R, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut. 2010; 59(6):714-721.
113. Patterson RN, Johnston BT, MacMahon J, Heaney LG, McGarvey LPA. Oesophageal pH monitoring is of limited value in the diagnosis of "reflux-cough." Eur Respir J. 2004; 24(5):724-727.
114. Poelmans J, Feenstra L, Demedts I, Rutgeerts P, Tack J. The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms. Am J Gastroenterol. 2004;99(8):1419- 1426.
115. Miner PB Jr. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux. Aliment Pharmacol Ther. 2006;23(suppl 1):25-32.
116. Park W, Hicks DM, Khandwala F, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope. 2005;115(7):1230-1238.
117. Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol. 2005;100(2):283-289.
118. Yang Y, Lewis J, Epstein S, Metz D. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006; 296(24):2947-2953.
119. Reimer C, Søndergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. 2009;137(1):80-87.
120. Niklasson A, Lindstrom L, Simren M, Lindberg G, Bjornsson E. Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. Am J Gastroenterol. 2010;105(7):1531- 1537.
121. Blondeau K, Dupont LJ, Mertens V, Tack J, Sifrim D. Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic cough. Aliment Pharmacol Ther. 2007;25(6): 723-732.
122. Dellon ES, Shaheen NJ. Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease. Gastroenterology. 2010;139(1):7-13.e13.
123. Tamhankar AP, Peters JH, Portale G, et al. Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg. 2004;8(7):890-897.
124. Tutuian R, Mainie I, Agrawal A, Adams D, Castell DO. Nonacid reflux in patients with chronic cough on acidsuppressive therapy. Chest. 2006;130(2):386-391.
125. Patterson N, Mainie I, Rafferty G, et al. Nonacid reflux episodes reaching the pharynx are important factors associated with cough. J Clin Gastroenterol. 2009;43(5):414-419.
126. Javorkova N, Varechova S, Pecova R, et al. Acidification of the oesophagus acutely increases the cough sensitivity in patients with gastro-oesophageal reflux and chronic cough. Neurogastroenterol Motil. 2008;20(2):119-124.
127. Agrawal A, Roberts J, Sharma N, Tutuian R, Vela M, Castell DO. Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus. 2009;22(5):467-470.
128. Hershcovici T, Mashimo H, Fass R. The lower esophageal sphincter. Neurogastroenterol Motil. 2011;23(9):819-830.
129. Dent J, Dodds WJ, Friedman RH, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest. 1980;65(2):256-267.
130. Johnston N, Wells CW, Samuels TL, Blumin JH. Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol. 2009;118(6):677-685.
131. Adhami T, Goldblum JR, Richter JE, Vaezi MF. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol. 2004;99(11): 2098-2106.
132. Decalmer S, Stovold R, Houghton LA, et al. Chronic cough: relationship between micro-aspiration, gastroesophageal reflux and cough frequency. Chest. 2012;142(4): 958-964.
133. Woodland P, Sifrim D. Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors. Curr Opin Gastroenterol. 2013;29(4): 431-436.
134. Wang A, Pleskow DK, Banerjee S, et al. Esophageal function testing. Gastrointest Endosc. 2012;76(2):231-243.
135. Kavitt RT, Higginbotham T, Slaughter JC, et al. Symptom reports are not reliable during ambulatory reflux monitoring. Am J Gastroenterol. 2012;107(12):1826-1832.
136. Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM. Chronic cough due to gastroesophageal reflux: clinical, diagnostic, and pathogenetic aspects. Chest. 1993;104(5): 1511-1517.
137. Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Chronic cough and gastro-oesophageal reflux: a double-blind placebo- controlled study with omeprazole. Eur Respir J. 2000; 16(4):633-638.
138. Orr WC. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management. Eur J Gastroenterol Hepatol. 2005;17(1):113-120.
139. Xu X, Chen Q, Liang S, Lu H, Qiu Z. Successful resolution of refractory chronic cough induced by gastroesophageal reflux with treatment of baclofen. Cough. 2012;8(1):8.
140. Faruqi S, Sedman P, Jackson W, Molyneux I, Morice AH. Fundoplication in chronic intractable cough. Cough. 2012; 8(1):3.
141. Bell RC, Mavrelis PG, Barnes WE, et al. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication. J Am Coll Surg. 2012;215(6):794-809.
142. Novitsky YW, Zawacki JK, Irwin RS, French CT, Hussey VM, Callery MP. Chronic cough due to gastroesophageal reflux disease: efficacy of antireflux surgery. Surg Endosc. 2002; 16(4):567-571.
143. Ganz RA, Peters JH, Horgan S, et al. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013; 368(8):719-727.
144. Irwin RS, Glomb WB, Chang AB. Habit cough, tic cough, and psychogenic cough in adult and pediatric populations: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1, suppl):174S-179S.
145. Bolser DC. Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1, suppl):238S-249S.
146. Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. Review series: chronic cough: behaviour modification therapies for chronic cough. Chron Respir Dis. 2007;4(2):89-97.
147. Lim KG, Rank MA, Hahn PY, Keogh KA, Morgenthaler TI, Olson EJ. Long-term safety of nebulized lidocaine for adults with difficult-to-control chronic cough: a case series. Chest. 2013;143(4):1060-1065.
148. Cohen SM, Misono S. Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review. Otolaryngol Head Neck Surg. 2013;148(3):374-382.
149. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebocontrolled trial. Lancet. 2012;380(9853):1583-1589.